Ozempic
- Product NDC
- 50090-5139
- Requested package NDC
- 50090-5139-0
- 11-digit product format
- 500905139
- Labeler code
- 50090
- Product ID
- 50090-5139_c4869820-1a83-42b5-8ba0-46fa98e373fd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- semaglutide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- A-S Medication Solutions
- Application
- NDA209637
- Marketing category
- NDA
- Marketing start
- 2017-12-06
- Marketing end
- 0000-00-00
- Substance
- SEMAGLUTIDE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 50090-5139 | 50090-5139-0 | I | Inactivated by FDA | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209637-001 | OZEMPIC | SEMAGLUTIDE | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | |
| N209637-002 | OZEMPIC | SEMAGLUTIDE | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | |
| N209637-003 | OZEMPIC | SEMAGLUTIDE | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | |
| N209637-004 | OZEMPIC | SEMAGLUTIDE | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | |
| N209637-005 | OZEMPIC | SEMAGLUTIDE | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N209637-006 | OZEMPIC | SEMAGLUTIDE | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N209637-007 | OZEMPIC | SEMAGLUTIDE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N209637-001 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2019-08-08 | |
| N209637-001 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2019-09-13 | |
| N209637-001 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | |
| N209637-001 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | |
| N209637-001 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2017-12-20 |
| N209637-001 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2019-04-04 | |
| N209637-001 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | |
| N209637-001 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2017-12-20 |
| N209637-001 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 10335462 | 2033-06-21 | U-2580 | 2019-07-25 | |
| N209637-002 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2020-09-24 |
| N209637-002 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | |
| N209637-002 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2020-09-24 |
| N209637-002 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 10335462 | 2033-06-21 | U-2580 | 2020-09-24 | |
| N209637-002 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-002 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | |
| N209637-003 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8536122 | 2026-03-20 | U-3355 | Drug substance, Drug product | 2022-04-29 |
| N209637-003 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2022-04-29 |
| N209637-003 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-003 | 12295988 | 2038-10-10 | U-2628 | 2025-05-29 | |
| N209637-004 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8536122 | 2026-03-20 | U-3469 | Drug substance, Drug product | 2022-11-14 |
| N209637-004 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8129343 | 2031-12-05 | U-3469 | Drug substance, Drug product | 2022-11-14 |
| N209637-004 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 10335462 | 2033-06-21 | U-2580 | Drug product | 2022-11-14 |
| N209637-004 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-004 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | |
| N209637-005 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2026-06-23 |
| N209637-005 | 12569543 | 2037-04-28 | U-4446 | 2026-06-23 | |
| N209637-005 | 10888605 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11752198 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 12214017 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11318191 | 2041-02-17 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11318191 | 2041-02-17 | U-4561 | Drug product | 2026-06-23 |
| N209637-006 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2026-06-23 |
| N209637-006 | 12569543 | 2037-04-28 | U-4446 | 2026-06-23 | |
| N209637-006 | 10888605 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-006 | 11752198 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N209637-001 | I-961 | 2028-01-28 |
| N209637-002 | I-961 | 2028-01-28 |
| N209637-003 | I-961 | 2028-01-28 |
| N209637-004 | I-961 | 2028-01-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-005 | OZEMPIC | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-006 | OZEMPIC | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-007 | OZEMPIC | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | d8e5a09893c0… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2019-08-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2019-09-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2017-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2019-04-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2017-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2017-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | 10335462 | 2033-06-21 | U-2580 | 2019-07-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2020-09-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2020-09-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2020-12-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 10335462 | 2033-06-21 | U-2580 | 2020-09-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | 8536122 | 2026-03-20 | U-3355 | Drug substance, Drug product | 2022-04-29 | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N209637-001 | I-961 | 2028-01-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-002 | I-961 | 2028-01-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-003 | I-961 | 2028-01-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N209637-004 | I-961 | 2028-01-28 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-004 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-001 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-002 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | D-185 | 2025-03-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-004 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-001 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-002 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | D-185 | 2025-03-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-004 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-001 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-002 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | D-185 | 2025-03-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-004 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-003 | D-185 | 2025-03-28 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-003 | D-185 | 2025-03-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-003 | D-185 | 2025-03-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-003 | D-185 | 2025-03-28 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-003 | D-185 | 2025-03-28 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N209637-003 | D-185 | 2025-03-28 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209637-003 | D-185 | 2025-03-28 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209637-003 | D-185 | 2025-03-28 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209637-003 | D-185 | 2025-03-28 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N209637-003 | D-185 | 2025-03-28 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-001 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-001 | I-822 | 2023-01-16 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-002 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-002 | I-822 | 2023-01-16 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-003 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-003 | D-185 | 2025-03-28 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-001 | NCE | 2022-12-05 | 5d02ea3f76ae… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 9dd2abc7-744f-456b-a273-dec083824bd8 | Product name | 2 | 20240229 |
| 487bac84-7c5b-40cf-afd2-8b9674d4648e | Product name | 1 | 20220118 |
| 21318a8d-e167-4f44-9627-3daede9532ff | Product name | 1 | 20200227 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-5139-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-356b-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use OZEMPIC ® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5139-0 | Ozempic | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 1 | |
| 50090-5139-0 | Ozempic | 1.5 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 1.5 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5139 | OZEMPIC (SEMAGLUTIDE) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS] | 1 | Legacy NDC, 2 package rows | 20210115_35902e95-e00c-47ae-8f4e-ba17d41881ce.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 42bdd912-2393-44c4-b7e0-47672ca28991 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 979e4df4-0597-48ea-b51c-0f699fa6d166 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
| OZEMPIC | SEMAGLUTIDE | A-S Medication Solutions | e6da837c-0da0-41d6-973c-5559bf764367 | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1991317 | OZEMPIC 2 MG in 1.5 ML Pen Injector, 1 MG Dose | PSN | 35902e95-e00c-47ae-8f4e-ba17d41881ce | 1 |
| 1991316 | semaglutide 2 MG in 1.5 ML Pen Injector, 1 MG Dose | PSN | 35902e95-e00c-47ae-8f4e-ba17d41881ce | 1 |
| 1991317 | 1 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector [Ozempic] | SBD | 35902e95-e00c-47ae-8f4e-ba17d41881ce | 1 |
| 1991316 | 1 MG Dose 1.5 ML semaglutide 1.34 MG/ML Pen Injector | SCD | 35902e95-e00c-47ae-8f4e-ba17d41881ce | 1 |
| 1991317 | 1 MG Dose 1.5 ML Ozempic 1.34 MG/ML Pen Injector | SY | 35902e95-e00c-47ae-8f4e-ba17d41881ce | 1 |
| 1991317 | OZEMPIC 2 MG per 1.5 ML Pen Injector, 1 MG Dose | SY | 35902e95-e00c-47ae-8f4e-ba17d41881ce | 1 |
| 1991316 | semaglutide 2 MG per 1.5 ML Pen Injector, 1 MG Dose | SY | 35902e95-e00c-47ae-8f4e-ba17d41881ce | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-5139-0 | 50090513900 | 2 SYRINGE, PLASTIC in 1 CARTON (50090-5139-0) > 1.5 mL in 1 SYRINGE, PLASTIC | 2020-08-31 | 0000-00-00 | No | No | Current |